Tyra Biosciences, Inc. Common Stock

TYRA US90240B1061

💰
Capitalization
Small-cap

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

Annual Performance 1
2021 2022 2023 2024 2025
-46% -46% 96% -1% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
73
🙍
Insiders
5
Person Price Shares Total Published Completed
Kaplan Gilla
9.78
USD
9,568
Sold
93,596
USD
17/06/2025 18/06/2025
Kaplan Gilla
9.78
USD
9,568
Sold
93,596
USD
17/06/2025 18/06/2025
Kaplan Gilla
10.35
USD
10
Sold
104
USD
17/06/2025 17/06/2025
Kaplan Gilla
10.35
USD
10
Sold
104
USD
17/06/2025 17/06/2025
Kaplan Gilla
10.38
USD
6,814
Sold
70,726
USD
12/06/2025 16/06/2025
Kaplan Gilla
10.38
USD
6,814
Sold
70,726
USD
12/06/2025 16/06/2025
Kaplan Gilla
10.31
USD
15,000
Sold
154,583
USD
12/06/2025 13/06/2025
Kaplan Gilla
10.31
USD
15,000
Sold
154,583
USD
12/06/2025 13/06/2025
Kaplan Gilla
10.31
USD
30,000
Sold
309,255
USD
12/06/2025 12/06/2025
Kaplan Gilla
10.31
USD
30,000
Sold
309,255
USD
12/06/2025 12/06/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Tyra Biosciences, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-49% -32% -21% -20% 0% 0% -47%
Last 52W Low 52W High All-Time Low All-Time High β
13.37 7.06 28.61 5.26 31.35
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Harris Todd 20 5,570,268.11 278,513.41 02/02/2024 21/10/2024
Kjellson Nina S 26 4,412,245.87 169,701.76 30/10/2024 05/02/2025
Bensen Daniel 16 2,184,835.37 136,552.21 02/02/2024 10/06/2024
Kaplan Gilla 10 1,256,526.00 125,652.60 12/06/2025 18/06/2025
Fuhrman Alan 1 151,954.40 151,954.40 30/10/2024 30/10/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.